Skip to main content
TipRanks
Go Ultimate75% OFF

Kailera Therapeutics, Inc. (KLRA) Stock Forecast & Price Target

61 Followers
See the Price Targets and Ratings of:

KLRA Analyst Ratings

Strong Buy
4Ratings
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Kailera Therapeutics, Inc. in the past 3 months

KLRA Stock 12 Month Forecast

$45.67â–²(244.13% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Kailera Therapeutics, Inc. in the last 3 months. The average price target is $45.67 with a high forecast of $57.00 and a low forecast of $36.00. The average price target represents a 244.13% change from the last price of $13.27.
Highest Price Target$57.00Average Price Target$45.67Lowest Price Target$36.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for KLRA
Price TargetArticle
Canaccord Genuity$44buy231.57%UpsideInitiated11/09/26
Leerink Partners Analyst forecast on KLRAUnknown AnalystNot RankedLeerink Partners$36buy171.29%UpsideReiterated11/05/26
William Blair―buy―Reiterated09/30/26
TD Cowen$57buy329.54%UpsideReiterated09/29/26
Jefferies$48buy261.72%UpsideReiterated08/14/26
J.P. Morgan$30buy126.07%UpsideReiterated08/12/26
Evercore ISI―buy―Initiated05/12/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
QUITAchieve Life Sciences
PALIPalisade Bio
KRSAKorsana Biosciences
HELPHelus Pharma
IRLAIRulya Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kailera Therapeutics, Inc.

3 Months
Yaron Werber
Yaron WerberTD Cowen
Success Rate1/4 ratings generated profit
25%
Average Return
-19.75%

Copying Yaron Werber's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -19.75% per trade.

1 Year
Yaron Werber
Yaron WerberTD Cowen
Success Rate1/4 ratings generated profit
25%
Average Return
-23.30%

Copying Yaron Werber's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -23.30% per trade.

2 Years
Yaron Werber
Yaron WerberTD Cowen
Success Rate1/4 ratings generated profit
25%
Average Return
-23.30%

Copying Yaron Werber's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -23.30% per trade.

KLRA Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for KLRA
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy65643
Buy72321
Hold00000
Sell00000
Strong Sell00000
total137964

In the current month, KLRA has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KLRA average Analyst price target in the past 3 months is 45.67.

KLRA Financial Forecast

$-3,651$-2,738.3$-1,825.5$-912.8$0Q2 2026Q1 2027
Consensus$-0.74

KLRA Earnings Forecast

Next quarter’s earnings estimate for KLRA is -$0.74 with a range of ― to ―. The previous quarter’s EPS was -$0.74. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q2 2026Q1 2027
Consensus$0.00

KLRA Sales Forecast

Next quarter’s sales forecast for KLRA is $0 with a range of ― to ―. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

KLRA Stock Forecast FAQ

What is KLRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Kailera Therapeutics, Inc.’s 12-month average price target is $45.67.
What is KLRA’s upside potential, based on the analysts’ average price target?
Kailera Therapeutics, Inc. has 244.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KLRA a Buy, Sell or Hold?
Kailera Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Kailera Therapeutics, Inc.’s price target?
The average price target for Kailera Therapeutics, Inc. is $45.67. This is based on 4 12-month price targets, issued in the past 3 months. The highest analyst price target is $57.00, the lowest forecast is $36.00. The average price target represents a 244.13% increase from the current price of $13.27.
What do analysts say about Kailera Therapeutics, Inc.?
Kailera Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of KLRA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.